Weekly Recap | Gilead Sciences +4.44%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 06:37 AMGILD-0.49%
Weekly Recap | Gilead Sciences -4.1%, sliding toward range lowsWeekly Review·Oct 3, 2026 at 06:52 AMGILD-0.49%
Weekly Recap | Gilead Sciences +0.55%, consensus target above spotWeekly Review·Sep 26, 2026 at 06:25 AMGILD-0.49%
